APVO
Aptevo Therapeutics Inc.
Key Financials
Revenue
$3.1M
0.0%
Operating Income
$-26312000
↓ 7.0%
Net Income
$-25967000
↓ 7.6%
Total Liabilities
$9.8M
↓ 9.4%
Shareholders' Equity
$17.4M
↑ 265.5%
Total Assets
$27.2M
↑ 74.4%
Cash & Equivalents
$21.6M
↑ 148.1%
Long-term Debt
$0.00
↓ 100.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 8/14/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | APVO |
| Company Name | Aptevo Therapeutics Inc. |
| CIK | 1671584 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 206-838-0500 |